The European Medicines Agency's (EMA) safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns regarding a possible increased risk of developing non ...

EMA says semaglutide may double the risk of NAION, a rare eye condition ... used for diabetes and obesity (Ozempic, Rybelsus, and Wegovy). After reviewing all available data on NAION with ...

Wegovy) or tirzepatide (Mounjaro, Zepbound). Some studies show a possible link between these drugs and eye issues like NAION, but the risk is very low. NAION is a rare and serious condition that ...

June 6 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab popular weight-loss and diabetes drugs Wegovy and Ozempic may ... "This has been reported as a potential risk for some time, so I ...

But there are steps you can take to reduce your risk. About 40 percent of new cancer diagnoses in U.S. adults age 30 and older are considered preventable, according to a study from the American ...

The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to healthcare workers over three years, the medicines watchdog has found.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Long-term cannabis use in any form has been linked to a greater risk of heart disease. In a new study, researchers at UC San Francisco determined that eating edible cannabis, such as gummies ...

Pivotal results from the Phase 3 BREAKWATER trial showed 51% risk reduction in death compared to standard-of-care treatment BRAFTOVI combination regimen also demonstrated 47% risk reduction in ...

Engagement with digital technology was associated with a 58 percent reduced risk of cognitive impairment in people middle-aged and older, according to a study in the journal Nature Human Behavior.